AquaBounty Technologies, Inc.

Compare this stock

AQB Stock Report Card

Today's performance

31%

Performance

Score:

10/100

AQB returned -82.65% in the last 12 months. Based on SPY's performance of 6.27%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

Score:

75/100

1 analysts offer 12-month price targets for AQB. Together, they have an average target of 0, the most optimistic target put AQB at 0 within 12-months and the most pessimistic has AQB at 0.

Sentiment

Score:

67/100

AQB had a bullish sentiment score of 66.84% across Twitter and StockTwits over the last 12 months. It had an average of 2.79 posts, 1.24 comments, and 1.71 likes per day.

Technicals

Score:

14/100

AQB receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.

Earnings

Score:

10/100

AQB has missed earnings 9 times in the last 20 quarters.

Profit

Score:

10/100

Out of the last 20 quarters, AQB has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

Score:

34/100

AQB has had a lower than average amount of volatility over the last 12 months giving it a score of 33 of 100.

AquaBounty Technologies, Inc. Summary

Nasdaq / AQB

Consumer Defensive

Agricultural Farm Products

AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.

Power up your portfolio